Autism Spectrum Disorder

USMLE Step 1 trap: Applies the outdated DSM-IV three-domain model instead of the DSM-5 two-domain model for autism. DSM-5 consolidates autism into two core domains: (1) deficits in social communication and interaction, and (2) restricted, repetitive behaviors — not three separate domains.

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition defined by two core symptom domains: deficits in social communication/interaction, and restricted, repetitive patterns of behavior. USMLE Step 1 tests this topic from three angles — DSM-5 criteria (especially the shift from DSM-IV), developmental red flags that should trigger referral, and the specific pharmacologic management of irritability. The exam loves to give you a vignette with a toddler who isn't making eye contact or pointing, or a child who regresses in language, and expects you to identify the correct diagnostic framework and next steps.

The tricky part is that most students learned or intuited a three-domain model (social, communication, behavior) from older sources or common sense — but DSM-5 explicitly collapses social interaction and communication into one domain. That distinction matters on test day. Similarly, regression — losing skills a child already had — is just as important a red flag as never acquiring them, and students often only watch for delayed milestones, not lost ones.

On the management side, USMLE Step 1 specifically distinguishes FDA-approved medications from off-label use. Applied behavioral analysis (ABA) is the cornerstone behavioral intervention, but when the question asks about pharmacologic management of irritability specifically, the answer is risperidone or aripiprazole — not SSRIs, which get used off-label for repetitive behaviors but have no FDA approval in this context. Know these distinctions cold.

From real student decks

41%have cards covering this topic

27%have mature cards

Common misconceptions

Common mistake

Wrong: DSM-5 autism requires deficits in three separate domains: social interaction, communication, and restricted behaviors.

Right: DSM-5 consolidates autism into two core domains: (1) deficits in social communication and interaction, and (2) restricted, repetitive behaviors — not three separate domains.

The DSM-IV split autism into three separate domains — social interaction, verbal/nonverbal communication, and restricted/repetitive behaviors — but DSM-5 eliminated this structure. Social communication and social interaction are now one unified domain, because deficits in these areas are so intertwined they can't be meaningfully separated. If you're applying a three-domain checklist on the exam, you're working from an outdated model. On USMLE Step 1, the right answer will reflect the two-domain DSM-5 structure.

Common mistake

Gap: Missing that developmental regression — not just delayed milestones — is a critical autism red flag

Loss of previously acquired language or social skills (regression) at any age is a red flag for autism spectrum disorder and warrants immediate evaluation.

Most students focus on what a child hasn't learned yet — delayed milestones — but regression is equally critical. Any loss of previously acquired language or social skills is a red flag for ASD (and also for rare conditions like Rett syndrome or Landau-Kleffner). The exam may describe a toddler who 'used to say five words but stopped' — that phrasing signals regression, and the correct response is immediate referral for ASD evaluation, not watchful waiting.

Common mistake

Wrong: SSRIs are FDA-approved for irritability in autism spectrum disorder.

Right: Risperidone and aripiprazole are the only FDA-approved medications for irritability associated with autism; SSRIs may be used off-label for repetitive behaviors but are not FDA-approved for this indication.

SSRIs are sometimes used in ASD for repetitive behaviors or comorbid anxiety, but this is entirely off-label — they are not FDA-approved for any ASD indication. Risperidone (approved 2006) and aripiprazole (approved 2009) are the only two FDA-approved medications for irritability specifically associated with ASD. When USMLE Step 1 asks about pharmacologic treatment of irritability in autism, the answer is one of these two atypical antipsychotics, not an SSRI.

Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →

Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

Know the two DSM-5 core domains for ASD diagnosis — social communication/interaction deficits as one unified domain, and restricted/repetitive behaviors as the second — and recognize that symptoms must be present in early development, even if they don't fully manifest until social demands exceed capacity.
Identify developmental red flags that warrant immediate ASD evaluation, including both failure to acquire milestones (e.g., no babbling by 12 months, no words by 16 months, no two-word phrases by 24 months) and regression — any loss of previously acquired language or social skills at any age.
Select the correct first-line behavioral intervention (applied behavioral analysis) and distinguish FDA-approved medications for ASD-related irritability (risperidone, aripiprazole) from off-label options like SSRIs, which are not approved for irritability in ASD.

Can you avoid these mistakes?

A parent brings in their 18-month-old who doesn't respond to his name, makes no eye contact, and has never pointed at objects. Which two DSM-5 domains does this child's presentation map onto, and which domain do his social and communication deficits fall under?

A 2-year-old girl had 10 words at 18 months but has stopped speaking over the past 2 months and no longer makes eye contact. Her developmental milestones were otherwise normal. What is the most appropriate next step, and what makes this presentation particularly concerning beyond typical ASD red flags?

A 7-year-old with ASD is brought in for evaluation of severe irritability and aggression that is disrupting his schooling. Behavioral interventions have been optimized. Which medication(s) have FDA approval specifically for this indication, and which drug class is commonly confused with them?

A vignette describes a child meeting criteria for ASD and asks you to identify which DSM-5 criterion is NOT required: (A) deficits in social communication and interaction, (B) restricted and repetitive behaviors, (C) symptoms present from early developmental period, (D) symptoms not better explained by intellectual disability alone, or (E) deficits in at least three separate behavioral domains. Which answer is the distractor and why?

Autism Spectrum Disorder

Common misconceptions

What the exam tests

Can you avoid these mistakes?

Related topics